Staci Pierce - 21 May 2025 Form 4 Insider Report for PROASSURANCE CORP (PRA)

Reporting relationship: Director
Issuer ticker: PRA
Reported as of: 21 May 2025
Net transaction value: +$94,979
SEC form: 4
Accepted by SEC: 21 May 2025, 17:05:04 UTC
Prior SEC filing: 11 Feb 2025
Next SEC filing: 25 Aug 2025
Source filing: View source filing
Reporting owner signature: Lee M. Pope, with Power of Attorney for the Reporting Person

Key filing fact

Staci Pierce filed Form 4 for PROASSURANCE CORP (PRA) on 21 May 2025.

Key facts

This page summarizes Staci Pierce's Form 4 filing for PROASSURANCE CORP (PRA).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 21 May 2025, 17:05.

Change

Previous filing in this sequence was filed on 11 Feb 2025.
Current net transaction value: +$94,979.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002021067 Primary reporting owner

Pierce Staci

Relationship: Director
Address: 100 BROOKWOOD PLACE, BIRMINGHAM
Signature: Lee M. Pope, with Power of Attorney for the Reporting Person
Signature date: 21 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PRA transaction

Common Stock

Award

Transaction value: $94,979
Shares: +4,101
Change %: +63%
Price: $23.16
Shares after: 10,621
Date: 21 May 2025
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These shares are awarded under the ProAssurance Corporation Director Deferred Stock Compensation Plan and are exempt under Rule 16b-3. This grant was recommended by the Compensation Committee, which is composed entirely of independent directors (as disclosed on page 14 of our 2025 Proxy Statement) and was approved by our Board of Directors at its meeting on May 21, 2025. This year, the recommended and approved stock compensation grant was for shares having a value not to exceed $95,000. The number of whole shares was determined using the closing price of a share of stock on the New York Stock Exchange (NYSE) on the day of the Board of Directors meeting following the Annual Meeting of Shareholders. The NYSE closing price on May 21, 2025 was $23.16, resulting in a distribution to each non-management director of 4,101 shares.